HLA-G
“Beyond the increasing complexity of the immunomodulatory HLA-G molecule”. Blood 111 (10): 4862–4870. (May 2008). doi:10.1182/blood-2007-12-127662. PMID 18334671.
“HLA-G: from biology to clinical benefits”. Trends in Immunology 29 (3): 125–132. (March 2008). doi:10.1016/j.it.2007.11.005. PMID 18249584.
“Primate Mhc-E and -G alleles”. Immunogenetics 46 (4): 251–266. (1997). doi:10.1007/s002510050271. PMID 9218527.
“HLA-G in the human placenta: expression and potential functions”. Biochemical Society Transactions 28 (2): 208–212. (February 2000). doi:10.1042/bst0280208. PMID 10816129.
“Structure--function relationships in HIV-1 Nef”.
04.006. PMID 15001239.
“HIV/SIV escape from immune surveillance: focus on Nef”. Current HIV Research 2 (2): 141–151. (April 2004). doi:10.2174/1570162043484924. PMID 15078178.
“Nef: "necessary and enforcing factor" in HIV infection”. Current HIV Research 3 (1): 87–94. (January 2005). doi:10.2174/1570162052773013. PMID 15638726.
“Antigen presenting cells and HLA-G--a review”. Placenta 26 (Suppl A): S104–S109. (April 2005). doi:10.1016/j.placenta.2005.01.006. PMID 15837058.
“HIV accessory proteins and surviving the host cell”. Current HIV/AIDS Reports 1 (1): 47–53. (April 2004). doi:10.1007/s11904-004-0007-x. PMID 16091223.